Variant Identified for Testicular Cancer Signals Heightened Risk for Later Cancers

Researchers identified two germline pathogenic variants in CHEK2 that may account for a minority of men diagnosed with testicular germ cell tumors.

Source: CancerNetwork - February 13, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news